Filing Flows

Filing Flows › Bio Green Med Solution (BGMS) › Q3 2025

Bio Green Med Solution (BGMS) Q3 2025 earnings results (third quarter 2025)

10-Q filed Nov 13, 2025

Bio Green Med Solution (BGMS) reported revenue of $81K for the third quarter 2025 (Q3 2025), +710% from a year earlier.

Revenue$81K
Year over year+710%
Quarter over quarter—
Operating margin—
Net earnings−$988K

Bio Green Med Solution, Q3 2025: revenue $81K (+710% year over year), net loss $988K, operating cash flow −$434K. The chart follows the revenue to costs, profit and cash.

Q3 2025AmountQ/QY/Y
Revenue$81K—+710%
Operating profit−$992K——
Net earnings−$988K——
Operating cash flow−$434K——

What changed

Revenue was $81K in Q3 2025, up 710% year over year.

Operating costs exceeded revenue by $1.0M, an operating margin of -1224.7%. Total costs fell 51% while revenue rose 710%. The quarter ended with a net loss of $1.0M.

Operating cash flow was −$434K. Non-cash charges added back $6K of share-based compensation. Working capital and other items added $548K.

Questions

What was Bio Green Med Solution's revenue in the third quarter 2025?

Bio Green Med Solution (BGMS) reported revenue of $81K for the third quarter 2025 (Q3 2025), +710% from a year earlier.

Open the interactive Sankey →

Source: Bio Green Med Solution 10-Q on SEC EDGAR.